Immunovant : ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline - IMVT, HSACU, HSAC, HSACW
NEW YORK, Feb. 26, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor... | March 4, 2021
Source: marketscreener.com